We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
-12.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.5M
AUM Growth
-$43.8M
Cap. Flow
-$15M
Cap. Flow %
-15.87%
Top 10 Hldgs %
63.27%
Holding
99
New
7
Increased
9
Reduced
24
Closed
13

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.89M
2
DVN icon
Devon Energy
DVN
+$2.41M
3
QTEK
QualTek Services Inc. Class A Common Stock
QTEK
+$2.23M
4
LNTH icon
Lantheus
LNTH
+$1.5M
5
DOCN icon
DigitalOcean
DOCN
+$1.2M

Top Sells

Rank Stock Value
1
ARCT icon
Arcturus Therapeutics
ARCT
+$5.77M
2
UTHR icon
United Therapeutics
UTHR
+$2.92M
3
META icon
Meta Platforms (Facebook)
META
+$2.52M
4
VIR icon
Vir Biotechnology
VIR
+$2.43M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 75.56%
2 Technology 13.28%
3 Energy 4.44%
4 Financials 2.35%
5 Communication Services 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUPH icon
26
Aurinia Pharmaceuticals
AUPH
$1.95B
$836K 0.88%
67,500
-121,000
-64% -$1.87M
AMZN icon
27
Amazon
AMZN
$2.94T
$652K 0.69%
4,000
– –
UPST icon
28
Upstart Holdings
UPST
$2.94B
$600K 0.63%
5,500
-100
-2% -$11.5K
COIN icon
29
Coinbase
COIN
$39.5B
$570K 0.6%
3,000
– –
CVX icon
30
Chevron
CVX
$366B
$570K 0.6%
3,500
-9,000
-72% -$1.29M
NTRA icon
31
Natera
NTRA
$39.4B
$509K 0.54%
12,500
-19,900
-61% -$1.2M
CSBR icon
32
Champions Oncology
CSBR
$73.6M
$508K 0.54%
62,500
– –
SURF
33
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$501K 0.53%
170,500
– –
IMDX
34
Insight Molecular Diagnostics
IMDX
$161M
$492K 0.52%
16,500
– –
CYPH
35
Cypherpunk Technologies Inc
CYPH
$78M
$464K 0.49%
26,500
+4,000
+18% +$85.5K
GLBE icon
36
Global E Online
GLBE
$6.98B
$422K 0.45%
12,500
-10,000
-44% -$377K
BTAI icon
37
BioXcel Therapeutics
BTAI
$26M
$418K 0.44%
1,250
– –
NGNE icon
38
Neurogene
NGNE
$718M
$374K 0.4%
9,950
-675
-6% -$39.4K
PDSB icon
39
PDS Biotechnology
PDSB
$40.6M
$371K 0.39%
60,000
– –
MTTR
40
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$325K 0.34%
40,000
-15,000
-27% -$142K
AFRM icon
41
Affirm
AFRM
$26.3B
$324K 0.34%
+7,000
New +$366K
DPRO
42
Draganfly
DPRO
$161M
$321K 0.34%
5,400
-2,400
-31% -$88.6K
RYTM icon
43
Rhythm Pharmaceuticals
RYTM
$7.62B
$317K 0.34%
27,500
– –
ONCT
44
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$313K 0.33%
11,250
-6,750
-38% -$246K
IMTX icon
45
Immatics
IMTX
$1.34B
$300K 0.32%
37,500
-26,000
-41% -$237K
CRDF icon
46
Cardiff Oncology
CRDF
$74.3M
$299K 0.32%
120,600
+18,100
+18% +$64K
AUD
47
DELISTED
Audacy, Inc.
AUD
$282K 0.3%
97,500
– –
BHVN
48
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$249K 0.26%
+2,100
New +$262K
GRTS
49
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$196K 0.21%
47,500
+7,500
+19% +$39.7K
MDNA
50
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$195K 0.21%
152,500
– –
1
2
3 4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, ACT Capital Management held 99 positions worth $94.5M, down 32% from $138M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

ACT Capital Management withdrew a net $15M in Q1 2022, closing 13 positions and reducing 24 holdings. Its most notable exit was United Therapeutics, an estimated $2.92M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 82% a quarter earlier, followed by Technology and Energy.

Against the trend, ACT Capital Management opened a new position in NVIDIA worth $4.23M.

  • ACT Capital Management's largest Q1 2022 buy was NVIDIA: 155,000 shares worth $4.23M.
  • ACT Capital Management added most to DigitalOcean in Q1 2022, an estimated $1.2M increase.
  • ACT Capital Management's biggest Q1 2022 reduction was Arcturus Therapeutics, cutting an estimated $5.77M.
  • ACT Capital Management fully exited United Therapeutics in Q1 2022, selling an estimated $2.92M.
  • ACT Capital Management's ten largest holdings make up 63% of its $94.5M portfolio in Q1 2022.
  • ACT Capital Management opened 7 new positions and closed 13 in Q1 2022.
  • ACT Capital Management's portfolio value fell 32% quarter-over-quarter to $94.5M.

Based on ACT Capital Management's 13F filing for Q1 2022, filed 11 May 2022.